Go Back This article was viewed 35 times

Case report


Plexiform Neurofibroma in the Axilla with Intraosseous Neurofibroma in the Humerus in Neurofibromatosis 5.

Sanjay Mhalasakant KhaladkarSurbhi ChauhanRaghav KalraShishir Chauhan
Department of Radiodiagnosis, Dr. D. Y. Patil Medical College and Research Center, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India
Date of Submission: 22-Oct-2017, Date of Acceptance: 04-Dec-2017, Date of Web Publication: 30-Jan-2018.
Corresponding Author:
Corresponding Author

Sanjay Mhalasakant Khaladkar

Department of Radiodiagnosis, Dr. D. Y. Patil Medical College and Research Center, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
E-mail: drsanjaymkhaladkar@gmail.com

Corresponding Author:
Corresponding Author

Sanjay Mhalasakant Khaladkar

Department of Radiodiagnosis, Dr. D. Y. Patil Medical College and Research Center, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
E-mail: drsanjaymkhaladkar@gmail.com

DOI: 10.4103/jcis.JCIS_76_17 Facebook Twitter Google Linkedin

ABSTRACT


Segmental neurofibromatosis type 5 (NF5) is a rare form of NF, in which the cutaneous and/or neural changes are confined to one region of the body. It is often underdiagnosed or undetected due to the absence of symptoms. Inheritance of NF is different from other types of NF. Intraosseous neurofibromas are rare tumors which develop from nerves supplying the periosteum or nerves following the intraosseous course. Plexiform neurofibroma with associated intraosseous neurofibroma is extremely rare. We report a case of plexiform neurofibroma in the left axilla of a 17-year-old female with associated intraosseous neurofibroma in adjoining left humerus.
Keywords: Intraosseous, neurofibromatosis, plexiform, segmental

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.